Evergreen Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.24M Buy
21,647
+609
+3% +$54.4K 0.04% 324
2026
Q1
$1.51M Sell
21,038
-1,186
-5% -$91.4K 0.03% 378
2025
Q4
$1.76M Buy
22,224
+2,504
+13% +$197K 0.04% 341
2025
Q3
$1.49M Sell
19,720
-368
-2% -$25.2K 0.04% 335
2025
Q2
$1.39M Buy
20,088
+203
+1% +$13.3K 0.04% 311
2025
Q1
$1.35M Buy
19,885
+7,579
+62% +$454K 0.05% 294
2024
Q4
$552K Sell
12,306
-267
-2% -$15K 0.02% 471
2024
Q3
$791K Buy
12,573
+909
+8% +$53K 0.03% 371
2024
Q2
$689K Sell
11,664
-167,793
-94% -$10.5M 0.02% 384
2024
Q1
$14.3M Buy
179,457
+3,775
+2% +$288K 0.54% 46
2023
Q4
$13.9M Sell
175,682
-4,437
-2% -$316K 0.57% 37
2023
Q3
$12.6M Sell
180,119
-3,373
-2% -$239K 0.55% 40
2023
Q2
$12.7M Buy
183,492
+78,543
+75% +$5.59M 0.53% 39
2023
Q1
$7.8M Buy
104,949
+3,316
+3% +$278K 0.35% 84
2022
Q4
$9.47M Sell
101,633
-920
-0.9% -$88.8K 0.45% 65
2022
Q3
$9.78M Sell
102,553
-28,657
-22% -$2.84M 0.51% 52
2022
Q2
$12.2M Buy
131,210
+239
+0.2% +$23.3K 0.63% 40
2022
Q1
$13.3M Buy
130,971
+3,027
+2% +$318K 0.54% 50
2021
Q4
$13.2M Buy
127,944
+6,144
+5% +$568K 0.53% 46
2021
Q3
$10.3M Buy
121,800
+10,743
+10% +$900K 0.47% 57
2021
Q2
$9.27M Sell
111,057
-28,772
-21% -$2.36M 0.44% 61
2021
Q1
$10.5M Buy
139,829
+9,498
+7% +$692K 0.54% 50
2020
Q4
$8.9M Buy
130,331
+124,478
+2,127% +$8.1M 0.52% 49
2020
Q3
$342K Sell
5,853
-140
-2% -$8.71K 0.02% 313
2020
Q2
$389K Sell
5,993
-246
-4% -$15.5K 0.03% 270
2020
Q1
$370K Sell
6,239
-719
-10% -$48K 0.03% 256
2019
Q4
$517K Buy
6,958
+1,964
+39% +$138K 0.04% 248
2019
Q3
$315K Sell
4,994
-246
-5% -$14.6K 0.03% 304
2019
Q2
$286K Buy
5,240
+1,139
+28% +$61.3K 0.03% 322
2019
Q1
$221K Sell
4,101
-1,013
-20% -$62.5K 0.02% 340
2018
Q4
$335K Buy
5,114
+475
+10% +$35.5K 0.04% 248
2018
Q3
$365K Sell
4,639
-4,574
-50% -$327K 0.03% 249
2018
Q2
$593K Buy
9,213
+5,470
+146% +$360K 0.06% 202
2018
Q1
$233K Sell
3,743
-33,655
-90% -$2.41M 0.02% 307
2017
Q4
$2.71M Buy
37,398
+822
+2% +$59.8K 0.27% 89
2017
Q3
$2.97M Buy
36,576
+1,297
+4% +$103K 0.35% 78
2017
Q2
$2.84M Buy
35,279
+2,435
+7% +$192K 0.46% 64
2017
Q1
$2.58M Sell
32,844
-3,710
-10% -$296K 0.54% 57
2016
Q4
$2.88M Buy
36,554
+29,723
+435% +$2.41M 0.56% 56
2016
Q3
$607K Buy
6,831
+120
+2% +$11.3K 0.12% 77
2016
Q2
$642K Sell
6,711
-17,731
-73% -$1.77M 0.14% 73
2016
Q1
$2.54M Buy
24,442
+527
+2% +$51.2K 0.58% 51
2015
Q4
$2.34M Sell
23,915
-627
-3% -$61.4K 0.56% 56
2015
Q3
$2.37M Buy
24,542
+808
+3% +$84.9K 0.61% 55
2015
Q2
$2.49M Sell
23,734
-300
-1% -$30.7K 0.61% 59
2015
Q1
$2.48M Sell
24,034
-19,308
-45% -$1.95M 0.55% 65
2014
Q4
$3.45M Sell
43,342
-50
-0.1% -$4.41K 0.68% 48
2014
Q3
$3.45M Buy
43,392
+405
+0.9% +$31.9K 0.67% 49
2014
Q2
$3.24M Buy
42,987
+52
+0.1% +$3.93K 0.64% 55
2014
Q1
$3.21M Sell
42,935
-715
-2% -$50.5K 0.65% 52
2013
Q4
$3.12M Buy
43,650
+201
+0.5% +$12.9K 0.57% 61
2013
Q3
$2.47M Buy
43,449
+475
+1% +$28.3K 0.4% 80
2013
Q2
$2.46M Buy
+42,974
New +$2.49M 0.38% 77

Other funds holding CVS

Evergreen Capital Management's CVS Position: Q2 2026 in Review

Evergreen Capital Management increased its CVS Health (CVS) stake by 2.9% in Q2 2026, buying an estimated $54.4K and bringing the position to 21,647 shares worth $2.24M. The position accounts for 0.04% of the portfolio, ranked #324.

Evergreen Capital Management first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.3M in Q1 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Evergreen Capital Management held 21,647 shares of CVS Health worth $2.24M as of Q2 2026.
  • Evergreen Capital Management bought 609 CVS Health shares in Q2 2026, an estimated $54.4K.
  • CVS Health made up 0.04% of Evergreen Capital Management's portfolio in Q2 2026, its #324 holding.
  • Evergreen Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Evergreen Capital Management's CVS Health position peaked at $14.3M in Q1 2024.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.